Fred Callori

Insider Reports History

Location
Boston, MA
Signature
/s/ Ben Harshbarger, as attorney-in-fact for Fred Callori
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Fred Callori:

Company Role Class Num Shares Value Price $ Report Date Ownership
Astria Therapeutics, Inc. Director Stock Option (Right to Buy) 26,550 11 Jun 2025 Direct
Landos Biopharma, Inc. Director Stock Option (right to buy) 0 23 May 2024 Direct

Insider Reports Filed by Fred Callori

Symbol Company Period Transactions Value $ Form Type Role Filing Time
ATXS Astria Therapeutics, Inc. 11 Jun 2025 1 $0 4 Director 12 Jun 2025, 17:51
ATXS Astria Therapeutics, Inc. 05 Jun 2024 1 $0 4 Director 06 Jun 2024, 16:06
/report/000141588924014340-callori-fred-2024-05-23 Landos Biopharma, Inc. 23 May 2024 3 $0 4 Director 23 May 2024, 17:45
ATXS Astria Therapeutics, Inc. 02 Jun 2023 1 $0 4 Director 06 Jun 2023, 08:04
/report/000120919123031941-callori-fred-2023-05-23 Landos Biopharma, Inc. 23 May 2023 1 $0 4 Director 24 May 2023, 17:51
ATXS Astria Therapeutics, Inc. 09 Jun 2022 1 $0 4/A Director 21 Jun 2022, 08:31
/report/000120919122035286-callori-fred-2022-06-07 Landos Biopharma, Inc. 07 Jun 2022 1 $0 4 Director 09 Jun 2022, 08:54
/report/000120919122030047-callori-fred-2022-05-16 Landos Biopharma, Inc. 16 May 2022 1 $0 4 Director 18 May 2022, 16:30
/report/000120919121054058-callori-fred-2021-08-27 Landos Biopharma, Inc. 27 Aug 2021 1 $0 4 Director 31 Aug 2021, 16:04
/report/000120919121054057-callori-fred-2021-08-27 Landos Biopharma, Inc. 27 Aug 2021 0 $0 3 Director 31 Aug 2021, 16:03
ATXS CATABASIS PHARMACEUTICALS INC 02 Jun 2021 1 $0 4 Director 02 Jun 2021, 19:18